Chile's Institute of Public Health Authorizes Emergency Use of Janssen's COVID-19 Vaccine through the COVAX Mechanism



Chile's Institute of Public Health (ISP) reported on 10 June 2021 that it was authorizing emergency use of Janssen's COVID-19 vaccine, which is included in the emergency use listing (EUL) of the World Health Organization (WHO) and indicated that Chile will receive it through the COVAX Facility. This vaccine requires only a single dose and is licensed for use in people 18 years of age and older.


  • Share: